BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 16289096)

  • 21. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
    J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Fas-induced apoptosis by Bcl-2.
    Kawahara A; Kobayashi T; Nagata S
    Oncogene; 1998 Nov; 17(20):2549-54. PubMed ID: 9840917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A; Nagata S; Tilg H
    Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells.
    Naujokat C; Sezer O; Possinger K
    Biochem Biophys Res Commun; 1999 Nov; 264(3):813-9. PubMed ID: 10544014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The three-dimensional solution structure and dynamic properties of the human FADD death domain.
    Berglund H; Olerenshaw D; Sankar A; Federwisch M; McDonald NQ; Driscoll PC
    J Mol Biol; 2000 Sep; 302(1):171-88. PubMed ID: 10964568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstitution of caspase-8 sensitizes JB6 cells to TRAIL.
    Kim IK; Chung CW; Woo HN; Hong GS; Nagata S; Jung YK
    Biochem Biophys Res Commun; 2000 Oct; 277(2):311-6. PubMed ID: 11032723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
    Mori S; Murakami-Mori K; Nakamura S; Ashkenazi A; Bonavida B
    J Immunol; 1999 May; 162(9):5616-23. PubMed ID: 10228045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.
    Martínez-Lorenzo MJ; Anel A; Gamen S; Monle n I; Lasierra P; Larrad L; Piñeiro A; Alava MA; Naval J
    J Immunol; 1999 Aug; 163(3):1274-81. PubMed ID: 10415024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells.
    Shao RG; Cao CX; Nieves-Neira W; Dimanche-Boitrel MT; Solary E; Pommier Y
    Oncogene; 2001 Apr; 20(15):1852-9. PubMed ID: 11313933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha.
    Gorak-Stolinska P; Truman JP; Kemeny DM; Noble A
    J Leukoc Biol; 2001 Nov; 70(5):756-66. PubMed ID: 11698496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The T cell death knell: immune-mediated tumor death in renal cell carcinoma.
    Uzzo RG; Kolenko V; Froelich CJ; Tannenbaum C; Molto L; Novick AC; Bander NH; Bukowski R; Finke JH
    Clin Cancer Res; 2001 Oct; 7(10):3276-81. PubMed ID: 11595725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissection of pathways leading to antigen receptor-induced and Fas/CD95-induced apoptosis in human B cells.
    Lens SM; den Drijver BF; Pötgens AJ; Tesselaar K; van Oers MH; van Lier RA
    J Immunol; 1998 Jun; 160(12):6083-92. PubMed ID: 9637525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tailless fas-FADD death-effector domain chimera is sufficient to execute Fas function in T cells but not B cells of MRL-lpr/lpr mice.
    Kabra NH; Cado D; Winoto A
    J Immunol; 1999 Mar; 162(5):2766-74. PubMed ID: 10072523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase-mediated cleavage of TRAF3 in FasL-stimulated Jurkat-T cells.
    Lee ZH; Lee SE; Kwack K; Yeo W; Lee TH; Bae SS; Suh PG; Kim HH
    J Leukoc Biol; 2001 Mar; 69(3):490-6. PubMed ID: 11261798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active alpha-lipoic acid.
    Sen CK; Sashwati R; Packer L
    Cell Death Differ; 1999 May; 6(5):481-91. PubMed ID: 10381641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
    Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways.
    Mountz JD; Zhou T; Su X; Cheng J; Pierson M; Bluethmann H; Edwards CK
    Behring Inst Mitt; 1996 Oct; (97):200-19. PubMed ID: 8950477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of Jurkat T cells rescued from CD95/Fas-induced apoptosis through the inhibition of caspases.
    Ko SC; Johnson VL; Chow SC
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1009-15. PubMed ID: 10772942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human fetal retinal pigment epithelial cells induce apoptosis in the T-cell line Jurkat.
    Farrokh-Siar L; Rezai KA; Semnani RT; Patel SC; Ernest JT; Peterson EJ; Koretzky GA; van Seventer GA
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1503-11. PubMed ID: 10359333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.